Pulsed estradiol exposure has a limited ability to induce uterine proliferation in ovariectomised female Wistar rats
- 31 January 2005
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 230 (1-2) , 7-15
- https://doi.org/10.1016/j.mce.2004.11.007
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal routeMaturitas, 2004
- Pulsed estrogen exposure selectively modulates tissue response: a hypothesisGynecological Endocrinology, 2004
- The Role of Selective Estrogen Receptor Modulators (SERMs) in Postmenopausal HealthAnnals of the New York Academy of Sciences, 2003
- Breast cancer and hormone-replacement therapy: the Million Women StudyPublished by Elsevier ,2003
- Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cellsJournal of Molecular Endocrinology, 2002
- The Influence of the Route of Administration of 17β-estradiol, Intravenous (Pulsed) Versus Oral, Upon DMBA-Induced Mammary Tumour Development in Ovariectomised RatsBreast Cancer Research and Treatment, 2002
- Endometrial safety and tolerability of AERODIOL® (intranasal estradiol) for 1 yearMaturitas, 2000
- Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulationsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1999
- The menopauseThe Lancet, 1999
- Proliferation markersExperimental and Toxicologic Pathology, 1996